4dx share price forecast

March 5, James Mickleboro. The latest member of the All Ordinaries index is getting some love this week.

The 4Dmedical Ltd stock price is 0. The 4DX stock price can go up from 0. The 4DX "4DX" future stock price will be 1. According to our analysis, this will not happen. Not within a year. See above.

4dx share price forecast

Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe. This share price information is delayed by 15 minutes. The overall consensus recommendation for 4DMedical is Buy. You can view the full broker recommendation list by unlocking its StockReport. To buy shares in 4DMedical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. Based on an overall assessment of its quality , value and momentum 4DMedical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. For more information, learn about our StockRank Styles. That is An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 4DMedical. You can read more about the power of momentum in assessing share price movements on Stockopedia. The 4DMedical PE ratio based on its reported earnings over the past 12 months is null.

Earnings and Revenue Growth Forecasts. Lilian is an independent director and is Chair of the Audit and Risk Committee.

EPS is expected to grow by Return on equity is forecast to be Earnings growth rate. Earnings vs Savings Rate: 4DX is forecast to remain unprofitable over the next 3 years. Earnings vs Market: 4DX is forecast to remain unprofitable over the next 3 years.

March 5, James Mickleboro. The latest member of the All Ordinaries index is getting some love this week. January 22, James Mickleboro. December 22, James Mickleboro. Analysts have put buy ratings on these small caps and see big potential returns. December 5, James Mickleboro. December 1, James Mickleboro. November 29, James Mickleboro. November 20, James Mickleboro. November 13, James Mickleboro.

4dx share price forecast

Key events shows relevant news articles on days with large price movements. Imugene Ltd. IMU 0. Pro Medicus Limited. PME 1. Dimerix Ltd. DXB 1. EBR Systems Inc. EBR 2. Polynovo Ltd.

Hcf by long division method class 6

The latest member of the All Ordinaries index is getting some love this week. She has also been in identifying and mentoring radiologists who push to address health disparities in research, advocacy efforts, artificial intelligence development, and medical student recruitment. Data provided by Morningstar. The technology uses existing imaging systems and allows X-ray images to be taken simultaneously from various angles. According to present data 4Dmedical Ltd's 4DX shares and potentially its market environment have been in a bullish cycle in the last 12 months if exists. Sep Today's Open. The overall consensus recommendation for 4DMedical is Buy. Lilian is an independent director and is Chair of the Audit and Risk Committee. Forecast to breakeven in Nov Current Price: 0. Sales Growth.

EPS is expected to grow by Return on equity is forecast to be Earnings growth rate.

Day Change. December 22, James Mickleboro. Issue of options. Based on an overall assessment of its quality , value and momentum 4DMedical is currently classified as a Neutral. Stable Share Price: 4DX's share price has been volatile over the past 3 months. After twelve years in London, Julian returned to Australia and formed a sales and marketing business helping best in class international fund management companies establish a presence in the Australian market. According to our analysis, this will not happen. Get It Now! Franking -. Open: 0. Currently, Julian is responsible for the sales and marketing function of Brown Advisory in Australia. Volume 1 month.